Daiichi Sankyo starts phase III of Enbrel biosimilar in Japan

Enbrel (Etanercept), a fully human soluble TNFα receptor preparation, is a therapeutic for rheumatoid arthritis.

Daiichi Sankyo news release, August 18, 2014

Most popular posts: